Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies

Current diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, leading to overdiagnosis and overtreatment. Aberrant promoter hypermethylation of specific genes has been suggested as novel candidate biomarkers for PC that may improve diagnosis and prognosis. We here analyzed ST6GALN...

Full description

Bibliographic Details
Main Authors: Christa Haldrup, Anne L. Pedersen, Nadia Øgaard, Siri H. Strand, Søren Høyer, Michael Borre, Torben F. Ørntoft, Karina D. Sørensen
Format: Article
Language:English
Published: Wiley 2018-04-01
Series:Molecular Oncology
Subjects:
biomarker
epigenetics
liquid biopsy
prostate cancer
ST6GALNAC3
ZNF660
Online Access:https://doi.org/10.1002/1878-0261.12183

Internet

https://doi.org/10.1002/1878-0261.12183

Similar Items